INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • April 29th, 2021 • LAVA Medtech Acquisition Corp. • Blank checks • New York
This Investment Management Trust Agreement (this “Agreement”) is made effective as of [ ], 2021, by and between LAVA Medtech Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
LAVA Medtech Acquisition Corp. 303 Wyman Street, Suite 300 Waltham, Massachusetts 02451Letter Agreement • April 29th, 2021 • LAVA Medtech Acquisition Corp. • Blank checks
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among LAVA Medtech Acquisition Corp., a Delaware corporation (the “Company”), RBC Capital Markets, LLC, as representative (the “Representative”) of the several underwriters (each, an “Underwriter” and collectively, the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of up to 10,000,000 of the Company’s units (including up to 375,000 units that may be purchased to cover over-allotments, if any) (the “Units”), each comprised of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), and one-half of one redeemable warrant. Each whole warrant (each, a “Warrant”) entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment. The Units will be sold in the Public Offering pursuant to a regi
REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENTRegistration and Shareholder Rights Agreement • April 29th, 2021 • LAVA Medtech Acquisition Corp. • Blank checks • New York
THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of [____], 2021, is made and entered into by and among LAVA Medtech Acquisition Corp., a Delaware corporation (the “Company”), LAVA Medtech Sponsor LP, a Delaware limited partnership (the “Sponsor”; together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).
LAVA MEDTECH ACQUISITION CORP. Waltham, Massachusetts 02451LAVA Medtech Acquisition Corp. • April 29th, 2021 • Blank checks • New York
This agreement (the “Agreement”) is entered into on March 31, 2021 by and between LAVA Medtech Sponsor LP, a Delaware limited partnership (the “Subscriber” or “you”), and LAVA Medtech Acquisition Corp., a Delaware corporation (the “Company”, “we” or “us”). Pursuant to the terms hereof, the Company hereby accepts the offer the Subscriber has made to purchase 2,875,000 shares (the “Shares”) of Class B common stock, $0.0001 par value per share (the “Class B Common Stock”) up to 375,000 of which are subject to forfeiture by you if the underwriters of the initial public offering (“IPO”) of units of the Company (the “Units”), do not fully exercise their over-allotment option (the “Over-allotment Option”). The Company and the Subscriber’s agreements regarding such Shares are as follows:
